tm logo
POLYSTART
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 30 Aug 2021

Last Applicant/ Owned by

33 5TH AVENUE NW

NEW BRIGHTON

MN

55112

Serial Number

90050163 filed on 13th Jul 2020

Registration Number

N/A

Correspondent Address

JAMES NAMIKI

DWC LAW FIRM, P.S.

PO BOX 3041

SEATTLE, WA 98114

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

POLYSTART

chimeric nucleic acid vector delivery systems administered in vivo or ex vivo to evaluate or elevate the expression of an encoded polypeptide or selected antigenic epitopes for medical purposes; chimeric nucleic acid administered in vivo or ex vivo to evaluate or elevate the expression of an encoded polypeptide or selected antigenic epitopes for medical purposes; chimeric nucleic acid-based immunoRead More

Classification Information


Class [001]
Chemical Products


chimeric nucleic acid and nucleic acid molecules for scientific use, namely, research and development use and for use in the manufacture of pharmaceuticals; chimeric nucleic acid and nucleic acid molecules for use in the manufacture of recombinant nucleic acids and recombinant polypeptides/proteins/antigenic determinants encoded thereby

Class [005]
Pharmaceutical Products


chimeric nucleic acid vector delivery systems administered in vivo or ex vivo to evaluate or elevate the expression of an encoded polypeptide or selected antigenic epitopes for medical purposes; chimeric nucleic acid administered in vivo or ex vivo to evaluate or elevate the expression of an encoded polypeptide or selected antigenic epitopes for medical purposes; chimeric nucleic acid-based immunotherapeutic and immunoprophylactic vaccines for the treatment of cancer and infectious disease; vaccine adjuvants

Class [042]
Computer & Software Services & Scientific Services


Medical and scientific research and development services in the field of vaccine technology specific to oncology or infectious diseases; Medical and scientific research and development services in the field of vaccine technology; Medical and scientific research and development services in the fields of nucleic acid expression technology, and evaluation of expressed protein, polypeptide, or antigenic epitopes; consulting services in the field of protein expression, vaccine technology, and the elevation of the expression of selected proteins, polypeptides and antigenic epitopes

Mark Details


Serial Number

No 90050163

Mark Type

No Service Mark

Attorney Docket Number

No 582A-232T-3

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Status DateAction Taken
30th Aug 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
30th Aug 2021ABANDONMENT - NO USE STATEMENT FILED
26th Jan 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01st Dec 2020PUBLISHED FOR OPPOSITION
01st Dec 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11th Nov 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
23rd Oct 2020APPROVED FOR PUB - PRINCIPAL REGISTER
22nd Oct 2020ASSIGNED TO EXAMINER
12th Aug 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
16th Jul 2020NEW APPLICATION ENTERED IN TRAM